Market cap data unavailable. We couldn't positively verify this ticker's market cap is under $500M. Verify independently before trading.
Vaso Corporation is a diversified enterprise engaged in both the healthcare equipment and information technology industries, serving markets within the United States and globally. The company's operations are structured across three primary divisions: 1. IT (Information Technology): This segment is dedicated to providing specialized IT solutions for the healthcare sector, alongside managed network technology services. Its services encompass managed diagnostic imaging applications, network infrastructure management, network transport, and comprehensive cybersecurity solutions. 2. Professional Sales Service: This division primarily focuses on the distribution of capital medical equipment manufactured by General Electric Healthcare (GEHC) to mid-sized healthcare providers. Its offerings include GEHC diagnostic imaging hardware, associated service contracts, training programs, and financial services facilitated by both GEHC and external partners. 3. Equipment: This segment concentrates on the development, manufacturing, sales, and servicing of its own proprietary medical devices. Its product portfolio features the Biox series, which includes Holter monitors and ambulatory blood pressure recorders; the ARCS series software for analyzing, reporting, and communicating ECG and blood pressure data; MobiCare multi-parameter wireless vital-sign monitoring systems; and Enhanced External Counterpulsation (EECP) therapy systems, used for non-invasive, outpatient treatment of ischemic heart disease. Founded in 1987, the company was originally named Vasomedical, Inc. before officially rebranding as Vaso Corporation in November 2016. Vaso Corporation maintains its corporate headquarters in Plainview, New York.
Vaso Corporation Announces Financial Results for Second Quarter of 2026
Vaso reported Q2 2026 revenue of $11.2 million, an 8.3% year-over-year increase, with net income of $542,000 reversing a prior-year loss.
Operating income improved significantly to $974,000 driven by higher gross margins, and the company completed its exit from IT services by selling the NetWolves network service business.
The balance sheet remains solid with $52.3 million in cash and cash equivalents and $41.5 million in deferred revenue at the end of the quarter.